Charlottesville, VA – According to filings with the U.S. Securities and Exchange Commission, Hemoshear Therapeutics is raising $48,102,069.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, James Powers played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Hemoshear Therapeutics

HemoShear Therapeutics is a clinical stage company developing new treatments for patients with rare metabolic disorders. We apply our deep understanding of complex diseases to discover breakthrough treatments for our proprietary pipeline.  We also partner with biopharma companies to accelerate their drug discovery and development programs in liver diseases, gout and metabolic disorders. We are implementing a new vision for how advanced biological systems can yield new insights that improve health and quality of life for patients in need.

To learn more about Hemoshear Therapeutics, visit http://www.hemoshear.com/

Contact:
James Powers, Chief Executive Officer
434-872-0196
powers@hemoshear.com
https://www.linkedin.com/in/jimcpowers/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved